Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Solid Tumor 1Recurrence 1Rectal Neoplasms 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Immunohistochemistry 3Observation 2Biopsy 2trastuzumab deruxtecan 1taxane 1Watchful Waiting 1Urination 1Tomography, X-Ray Computed 1Tegafur 1Taxes 1Surveys and Questionnaires 1S 1 (combination) 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum Compounds 1Oxaliplatin 1Minimally Invasive Surgical Procedures 1Microbiota 1Methylation 1Mass Spectrometry 1Liquid Biopsy 1Leucovorin 1Irinotecan 1Hyperthermic Intraperitoneal Chemotherapy 1Gene Expression Profiling 1Gemcitabine 1Frozen Sections 1Fluorouracil 1Epirubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Gallbladder Neoplasms × Tegafur × Clear all
NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Fudan University

Unknown
160 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡